A Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma

Condition:   Multiple Myeloma Interventions:   Drug: Cevostamab;   Drug: XmAb24306;   Drug: Tocilizumab Sponsor:   Genentech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Myeloma | Research | Study